Amgen's Oncology Strategy: Building A Pipeline Of Novel Paradigm-Changing Drugs

 
• By Mandy Jackson
T-cells attacking cancer_1200x675
Amgen's BiTE molecules recruit T-cells to targeted tumors. • Source: Shutterstock

More from Anticancer

More from Therapeutic Category